Pilot Study of Lychee Fruit Extract to Promote Cardiovascular Health

Effects of Lychee Fruit Extract on Vascular Function and Inflammation in Postmenopausal Women: a Double-Blind, Crossover Study

The investigators hypothesize that acute and short term consumption of a lychee fruit extract, particularly rich in low molecular weight dietary flavanols, will improve vascular function and reduce platelet reactivity.

Study Overview

• Status: Completed
• Conditions: Cardiovascular Health
• Intervention / Treatment: Dietary supplement: Lychee Fruit Extract

Detailed Description

Several large-scale epidemiologic studies have indicated that chronic consumption of flavonoid-rich foods appear to be associated with decreased risk for several chronic diseases including cancer, diabetes, cardiovascular disease, and stroke. In humans, consumption of several flavonoid-rich foods and beverages, such as berries, teas, cocoa, and grapes have been reported to improve vascular endothelial function and decrease platelet reactivity. Previous work at UC Davis by Dr. Keen and colleagues has helped define the role of flavanols in vascular function, and has used a flavanol-rich cocoa extract as the test material. In this proposed study, we seek to explore the role of a lychee fruit extract rich in flavanols, and its effects of vascular and metabolic parameters.

• Study Type: Interventional
• Enrollment (Actual): 44
• Phase: Phase 1

Contacts and Locations

Study Locations

• United States
  • California
    • Davis, California, United States, 95616
      • Ragle Human Nutrition Research Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Female Age 52 to 65 yrs.
• Male Age 18 to 35 yrs.
• Female and male >110 pounds
• Lack of menses in the last year and FSH 23-116.3 mIU/mL
• Subject is willing and able to comply with the study protocols.
• Subject is willing to consume the lychee fruit extract or placebo capsule twice a day.
• BMI 20-35 kg/m2

Exclusion Criteria:

• Physical signs of health impairment
• Weight < 110 pounds
• BMI >35 kg/m2
• Blood Pressure > 140/90 mm Hg
• Diabetes
• Inability to properly place or wear the PAT probes or abnormal measurements on pre-screening PAT
• Abnormal clinical laboratory test (CBC, comprehensive metabolic panel, etc.) if determined to be clinically significant by Dr. M. Eric Gershwin.
• PFA-100 readings 10% outside of normal reference range (normal reference range for ADP-Collagen cartridge: 71-118 sec; Epinephrine-Collagen cartridge: 94-193 sec).
• Inflammatory disorders (e.g. rheumatoid arthritis)
• Malabsorption
• Treatment with corticosteroids, hypolipidemic and anti-inflammatory drugs
• Renal or liver disease
• History of cancer
• Heart disease, which includes cardiovascular events and Stroke
• Cushing's syndrome
• History of psychiatric disorders i.e. schizophrenia or bi-polar or depression treated with antidepressants within the last 1 year.
• Anxiety medications
• Routine use of prescription drugs or over-the counter medications, which may potentially modulate the outcome of this study; including antibiotics, aspirin and aspirin-containing formulations, COX-2 inhibitors, antihistamines, corticosteroids
• Asthma (can be worsened by mild to moderate food allergies)
• Indications of substance or alcohol abuse within the last 3 years
• Multi-vitamin and mineral use other than a general formula, once per day tablet
• Use of herbal or plant-based supplements; omega-3 fatty acids, and fish oils in the past 3-6 months, and unwilling to discontinue use while participating in the study
• Alcohol consumption > 1 oz/day (2 beers/day or 2 glasses of wine/ day, 1 drink of hard liquor/day)
• Allergies to fruit
• Chronic/routine high-intensity exercise
• Smoking or actively in smoking cessation therapy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Quadruple

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: 100 mg of Lychee fruit extract	Dietary supplement: Lychee Fruit Extract; placebo or 100, 200 and 600 mg of lychee fruit extract for 2 weeks with one week washout period between treatments 2000 mg of lychee fruit extract given at a single visit
Experimental: 200 mg of Lychee fruit extract	Dietary supplement: Lychee Fruit Extract; placebo or 100, 200 and 600 mg of lychee fruit extract for 2 weeks with one week washout period between treatments 2000 mg of lychee fruit extract given at a single visit
Experimental: 600 mg of Lychee fruit extract	Dietary supplement: Lychee Fruit Extract; placebo or 100, 200 and 600 mg of lychee fruit extract for 2 weeks with one week washout period between treatments 2000 mg of lychee fruit extract given at a single visit
Experimental: 2000 mg of Lychee fruit extract	Dietary supplement: Lychee Fruit Extract; placebo or 100, 200 and 600 mg of lychee fruit extract for 2 weeks with one week washout period between treatments 2000 mg of lychee fruit extract given at a single visit

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Peripheral Arterial Tonometry	0, 2 and 4 hours

Collaborators and Investigators

• Sponsor: University of California, Davis
• Investigators: Principal Investigator: Robert M Hackman, PhD, University of California, Davis

Study record dates

Study Major Dates

• Study Start: April 1, 2009
• Primary Completion (Actual): July 1, 2010
• Study Completion (Actual): July 1, 2010

Study Registration Dates

• First Submitted: July 12, 2010
• First Submitted That Met QC Criteria: July 13, 2010
• First Posted (Estimate): July 14, 2010

Study Record Updates

• Last Update Posted (Estimate): August 23, 2010
• Last Update Submitted That Met QC Criteria: August 19, 2010
• Last Verified: August 1, 2010

More Information

Terms related to this study

• Keywords: Cardiovascular; Postmenopausal Women; Flavanols; Healthy Males
• Other Study ID Numbers: 200916915-2